Axsome Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Axsome Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q4 2024.
  • Axsome Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $22M, a 26.5% increase year-over-year.
  • Axsome Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $85.2M, a 36.1% increase year-over-year.
  • Axsome Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $85.2M, a 36.1% increase from 2023.
  • Axsome Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $62.6M, a 66% increase from 2022.
  • Axsome Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $37.7M, a 181266% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $85.2M $22M +$4.6M +26.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-18
Q3 2024 $80.6M $21.7M +$5.29M +32.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $75.3M $21.4M +$5.46M +34.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $69.9M $20.2M +$7.25M +56% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $62.6M $17.4M -$20.3M -53.9% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-18
Q3 2023 $82.9M $16.4M +$16.4M +177871% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $66.6M $15.9M +$15.9M +156582% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $50.7M $12.9M +$12.9M +170247% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $37.7M $37.7M +$52.6M Oct 1, 2022 Dec 31, 2022 10-K 2025-02-18
Q3 2022 -$14.9M $9.2K -$5.72M -99.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$9.15M $10.2K -$5.45M -99.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$3.7M $7.6K -$3.72M -99.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $20.8K -$14.9M -$20.5M -366% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $20.5M $5.73M +$2.86M +99.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $17.7M $5.46M +$1.31M +31.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $16.4M $3.73M +$1.6M +74.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
Q4 2020 $14.8M $5.61M +$2.79M +99.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $12M $2.87M +$1.71M +148% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $10.3M $4.15M +$3.26M +367% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $6.99M $2.13M +$877K +69.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $6.12M $2.81M +$2.46M +697% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $3.65M $1.16M +$764K +195% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $2.89M $889K +$414K +87.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $2.48M $1.26M +$722K +135% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $1.75M $353K -$184K -34.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $1.94M $393K +$4.62K +1.19% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.93M $475K -$8.97K -1.86% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.94M $535K -$129K -19.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $2.07M $537K +$102K +23.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $1.97M $388K -$70.4K -15.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.04M $484K +$1.6K +0.33% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $2.04M $664K +$7.42K +1.13% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $2.03M $435K +$252K +138% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $1.78M $458K +$97.7K +27.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $1.68M $482K +$297K +160% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $1.38M $656K +$581K +778% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $803K $182K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 $361K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $185K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $74.8K Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.